Avantis Medical Systems, Inc., the Sunnyvale, Calif. based creator of the Third Eye Retroscope–a device that adds an extra view to a colonoscope, has raised $3,048,468 of venture capital to further commercialize its flagship product in the U.S., make small improvements to the product, as well as using a “little bit” work toward earning a CE Mark in Europe, President and CEO Tony DiTonno said.
The company, in Series D funding, seeks about $4.95 million more, according to the regulatory filing it made with the SEC.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
DiTonno said he expects the company to be acquired in 18 months to two years.
The officers and directors listed on the filing include DiTonno, who previously served as CEO for NeurogesX and LifeSleep; Director Dr. Thomas Fogarty; former Director Matthew Jenusaitis; Director Dr. Camran Nezhat, a general partner at CN Investment; Director Howard Palefsky, managing director at Montreux Equity Partners; and Director Dr. John Savarese, also a managing director at Montreux Equity.